Panion & BF Biotech Inc values innovation, scientific excellence, and a commitment to improving human and animal health. The company is a biotechnology firm specializing in the development and commercialization of novel therapeutics for various diseases. Panion & BF Biotech Inc follows a corporate philosophy centered around research-driven approaches, collaboration with global partners, and ethical business practices. With a strong emphasis on advancing healthcare and addressing unmet medical needs, Panion & BF Biotech Inc strives to create value for patients, shareholders, and the broader society.

Panion & BF Biotech Inc is primarily present in Taiwan.

Panion & BF Biotech Inc. has achieved several significant milestones in its journey. One of the notable accomplishments includes the successful development and commercialization of innovative biotechnological products. The company has also established strong strategic partnerships with renowned pharmaceutical companies and research institutions. Moreover, Panion & BF Biotech Inc. has demonstrated consistent growth in its market presence and financial performance, which has garnered recognition from industry experts and investors. These achievements highlight the company's commitment to excellence and reinforce its position as a leading player in the biotech sector. Panion & BF Biotech Inc.'s dedication to innovation and strategic collaborations has enabled it to make remarkable strides in advancing healthcare solutions.

Panion & BF Biotech Inc is a pharmaceutical company that specializes in the development and production of animal health products. Founded in 2008, the company is based in Taiwan and has gained recognition worldwide for its expertise in the field of biotechnology. Panion & BF Biotech Inc has a strong commitment to research and innovation, continually seeking new solutions to improve animal health and welfare. With a dedicated team of professionals, the company has built a solid reputation for delivering high-quality products that meet the needs of both animals and their owners. Today, Panion & BF Biotech Inc continues to be a leading player in the animal health industry, making significant contributions to veterinary care.

Some of the main competitors of Panion & BF Biotech Inc in the market include company A, company B, and company C. These competitors also operate in the same industry and offer similar products and services as Panion & BF Biotech Inc. However, Panion & BF Biotech Inc distinguishes itself through its innovative research and development, strong market presence, and high-quality products. As a leading player in the industry, Panion & BF Biotech Inc competes effectively by continuously improving its offerings and maintaining a strong customer base.

Panion & BF Biotech Inc is primarily active in the biotechnology industry.

The business model of Panion & BF Biotech Inc is focused on developing and commercializing innovative solutions in the field of biotechnology. They primarily specialize in the research, development, and production of animal health products, specifically for livestock. Panion & BF Biotech Inc strives to improve animal health and contribute to the overall sustainability of the agricultural industry. They aim to provide effective and safe solutions to prevent and treat various animal diseases, ensuring the well-being and productivity of livestock. With a strong commitment to innovation and research, Panion & BF Biotech Inc continues to drive advancements in the biotechnology sector.

Το Panion & BF Biotech P/E είναι 57,45.

Το KUV της εταιρείας Panion & BF Biotech είναι 3,85.

Το AlleAktien Qualitätsscore για το Panion & BF Biotech είναι 7/10.

Ο κύκλος εργασιών του αναμενόμενη Panion & BF Biotech είναι 2,09 δισ. TWD.

Το αναμενόμενη Panion & BF Biotech κέρδος είναι 139,93 Εκ. TWD.

The company Panion & BF Biotech Inc is a biopharmaceutical company based in Denmark and Taiwan. The company's business model is based on the development and marketing of biotechnological products for animal health. The company focuses on the areas of neuropathic pain in dogs and replacement therapy for diabetic animals.

Η Panion & BF Biotech καταβάλλει μια διανομή της τάξεως των 1,50 TWD διαμοιρασμένη σε δόσεις ετησίως.

Το μέρισμα δεν μπορεί να υπολογιστεί για το Panion & BF Biotech αυτή τη στιγμή ή η εταιρεία δεν διανέμει μέρισμα.

Ο αριθμός ISIN της Panion & BF Biotech είναι TW0001760007.

Ο τίκερ της Panion & BF Biotech είναι 1760.TW.

Κατά τους τελευταίους 12 μήνες η Panion & BF Biotech κατέβαλε μια μέρισμα ύψους 2,00 TWD . Αυτό αντιστοιχεί σε απόδοση μερίσματος περίπου 2,13 %. Για τους επόμενους 12 μήνες, η Panion & BF Biotech προβλέπεται να πληρώσει μέρισμα 2,00 TWD.

Η απόδοση μερίσματος της Panion & BF Biotech ανέρχεται σήμερα στο 2,13 %.

Panion & BF Biotech πληρώνει τέταρτον διανεμητέου μισθό. Αυτή καταβάλλεται τους μήνες Ιουλίου, Ιουλίου, Αυγούστου, Ιουλίου.

Η Panion & BF Biotech πλήρωσε κάθε χρόνο μέρισμα μέσα στα τελευταία 10 έτη.

Για τους επόμενους 12 μήνες αναμένονται μερίσματα σε ύψος των 2,00 TWD. Αυτό αντιστοιχεί σε απόδοση μερίσματος 2,13 %.

Το Panion & BF Biotech ανατίθεται στον τομέα 'Υγεία'.

Για να λάβεις το τελευταίο μέρισμα των Panion & BF Biotech από την 10/7/2024 με τιμή 1,5 TWD, έπρεπε να έχεις τη μετοχή στο χαρτοφυλάκιο σου πριν από την ημέρα Ex-Tag στις 13/6/2024.

Η τελευταία μερίσματος έγινε στις 10/7/2024.

Το έτος 2023, η Panion & BF Biotech διένειμε 1,5 TWD ως μερίσματα.

Τα μερίσματα του Panion & BF Biotech καταβάλλονται σε TWD.